Grégory Driessens
79 works · 3,306 citations · h-index 18
Top works
- Defining the mode of tumour growth by clonal analysis
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
- A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
- Costimulatory and coinhibitory receptors in anti‐tumor immunity
- 74 Abstract withdrawn
- Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo
- β-Catenin Inhibits T Cell Activation by Selective Interference with Linker for Activation of T Cells–Phospholipase C-γ1 Phosphorylation
- β-catenin does not regulate memory T cell phenotype
- A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
- Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
- Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors
- Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
- Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour
- Long Live Sox2: Sox2 Lasts a Lifetime
- Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors
- Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery
- Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
- Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor